|
業務類別
|
-- |
|
業務概覽
|
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company's products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of world, with the majority of its revenue generated from Canada. |
| 公司地址
| 10 Carlson Court, Suite 701, Etobicoke, Toronto, ON, CAN, M9W 6L2 |
| 電話號碼
| +1 647 495-9000 |
| 傳真號碼
| +1 416 213-0045 |
| 公司網頁
| https://www.hlstherapeutics.com |
| 員工數量
| 86 |
| Dr. Jason A. Gross,PhD |
Vice President, Scientific Affairs |
-- |
05/06/2026 |
| Mr. John Hanna |
Chief Financial Officer and Director |
-- |
05/06/2026 |
| Mr. Ryan C. Lennox |
Senior Vice President, Legal, Human Resource and Compliance and Corporate Secretary |
-- |
05/06/2026 |
| Mr. Craig Stuart Millian |
Director and Chief Executive Officer |
-- |
05/06/2026 |
| Ms. Patricia Perry |
Vice President, Human Resources |
-- |
12/03/2026 |
| Mr. David Spence |
Vice President and Corporate Controller |
-- |
12/03/2026 |
| Mr. Dawn Edinboro |
Vice President; General Manager of Heritage Life Sciences (Barbados) Inc. |
-- |
12/03/2026 |
| Mr. Brian T. Walsh |
Chief Commercial Officer |
-- |
05/06/2026 |
|
|
| Ms. Norma Beauchamp |
Independent Director |
05/06/2026 |
| Mr. John Hanna |
Chief Financial Officer and Director |
05/06/2026 |
| Mr. John L. Welborn, Jr |
Chairman of the Board |
05/06/2026 |
| Mr. Rodney Hill |
Independent Director |
05/06/2026 |
| Mr. Craig Stuart Millian |
Director and Chief Executive Officer |
05/06/2026 |
| Mr. Kyle Dempsey |
Independent Director |
05/06/2026 |
| Mr. Christian Roy |
Independent Director |
05/06/2026 |
| Ms. Christine Elliott |
Director |
05/06/2026 |
|
|
|
|
